NephroGenex

Sector:
Healthcare

Location:
Cary, NC

Year Funded:
2008

Status:
Active

Website:
www.nephroGenex.com


Summary:
NephroGenex is a drug development company focusing on kidney disease. The company is developing Pyridorin™ (pyridoxamine dihydrochloride) as a treatment to slow the progression of diabetic kidney disease. Pyridorin™ has demonstrated a significant treatment effect in slowing the progression of diabetic nephropathy in two Phase IIa clinical trials, and has been awarded Fast Track status by the FDA.